Ketamine, esketamine, and ECT can rapidly ease suicidal thoughts, but evidence for preventing attempts or deaths remains limited—see what’s proven.
|Slideshows|November 3, 2017
4 Clinical Reports on Brain Stimulation
Author(s)Raymond Cho, MD, MSc
This slideshow provides a snapshot of innovative alternatives to traditional treatments for psychiatric disorders.
Advertisement
The 4 clinical reports mentioned in this slideshow:Deep Brain Stimulation for Memory DeficitsTranscranial Magnetic Stimulation and SchizophreniaWhat Psychiatrists Need to Know About Transcranial Direct Current StimulationLeft to Their Own Devices: Issues in the Informed Consent Process for Transcranial Direct Current StimulationÂ
Advertisement
Related to this article
Learn how clozapine, lithium, ketamine, and antidepressants fit into suicide prevention, from rapid crisis relief to long-term risk reduction.
Courts cite teen brain science to soften sentences; experts warn generalized neuroscience overreaches and adult responsibility stabilizes by 18 to 20.
Can hormones flag suicide risk in schizophrenia? Review links cortisol, thyroid and testosterone shifts—and clozapine/lithium pathways—to risk.
How VA clinicians treat veterans’ PTSD while managing suicide risk, using shared decisions, safety planning, and phase-based trauma therapies.
Medicare claims show pimavanserin in Parkinson psychosis nursing homes links to fewer falls and recurrent falls than quetiapine or other antipsychotics.
Learn how to prevent and spot tardive dyskinesia from antipsychotics, track key risk factors, and treat symptoms with VMAT2 inhibitors.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Nature vs Nurture: The Interplay Between Genetics and Environmental Influences
2
AI as a Task-Replacing Tool for Psychiatric Care: A Conversation With Christoph Correll, MD
3
Brain Trust: Therapeutic Drug Monitoring and Adherence in Schizophrenia, With Jonathan M. Meyer, MD
4
What Clinicians Need to Know About Postpartum Psychosis
5